PDUFA coming end of July for zircaix. The FDA will conduct its own review of the product during this period. Considering this drug was granted priority review status because of the unmet medical need I am assuming this date to be set will be in 4-6 months.
Hopefully the review goes well and they speed it up so first sales can start by Christmas
Also just something else to add. I see rapid take up of this drug. Not only does the same urology practice that sells illuccix also treat renal cancers but they would already have used this product on compassionate grounds. It’s already being used and they see the effectiveness of it. For those two reasons the product sells itself. Just need the licence to sell it.
Ann: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade, page-51
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.45 |
Change
0.520(2.48%) |
Mkt cap ! $7.178B | |||
| Open | High | Low | Value | Volume |
| $20.83 | $21.50 | $20.80 | $17.54M | 824.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2037 | $21.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.50 | 12320 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |